Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors
NCT00345189
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
70
Enrollment
INDUSTRY
Sponsor class
Conditions
Tumors
Lymphoma
Interventions
DRUG:
CNF2024
Sponsor
Biogen